Alivexis

Home | Alivexis, Inc.

Tokyo, Japan · Founded 2016 · $51.9M raised

Headquarters
Tokyo
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$51.9M
Last Round
$6.0M Series DJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Alivexis, Inc. (formerly Modulus Discovery) is a technology-driven drug discovery enterprise with operations in both Tokyo, Japan and the United States. The company leverages its proprietary ModBind computational platform — which uses GPU-optimized molecular simulation and AI — to discover novel small-molecule therapeutics targeting cancer, immune-inflammatory conditions, and rare diseases. Alivexis pursues an asset-light, network-based R&D model, partnering with global pharmaceutical companies including Astellas Pharma, and has advanced multiple clinical candidates through its portfolio of discovery programs since its founding in August 2016.

Summary

Alivexis is an Artificial Intelligence company based in Tokyo, Japan, founded in 2016. It has raised $51.9M in total across 3 rounds, most recently a $6.0M Series D round in Jan 2025. Investors include JIC Venture Growth Investments, DBJ Capital Corporation and Fast Track Initiative,.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DJan 2025
$6.0M

Sign up to see all 3 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alivexis on Indexed.vc
<a href="https://indexed.vc/companies/alivexis"><img src="https://indexed.vc/api/badge/company/alivexis" alt="Alivexis on Indexed.vc" width="260" height="76" /></a>